AMCP 2024: Behind the research with Jacob LaRue and Timothy O’Shea - Prime Therapeutics
AMCP 2024: Behind the research with Jacob LaRue and Timothy O’Shea
Ahead of their session, Jacob and Timothy share how Prime/MRx is working alongside providers like Horizon Blue Cross Blue Shield of New Jersey to manage drug waste and rein in spend for specialty drugs without therapeutic impact to patients
It’s day one of the Academy of Managed Care Pharmacy (AMCP)’s Annual Meeting 2024 in New Orleans, and the energy inside the Ernest N. Morial Convention Center is high as leaders from across the health care space — including Prime Therapeutics/MagellanRx Management (Prime/MRx) — tackle some of the most pressing issues facing the industry.
A key factor driving health care spend today is high-cost specialty drugs, which are often used to treat severe diseases and conditions. That was the focus of the day-one session, “You Can Round That! Establishing and Managing Mandatory Drug Wastage Programs,” featuring Jacob LaRue, assistant vice president of specialty clinical solutions at Prime/MRx, and Timothy O’Shea, manager of clinical pharmacy at Horizon Blue Cross Blue Shield of New Jersey.
We caught up with Jacob and Timothy earlier today to hear how Prime/MRx is working alongside providers, like Horizon Blue Cross Blue Shield of New Jersey, to manage drug waste and rein in spend for specialty drugs without therapeutic impact to patients.
Stay tuned for additional coverage from AMCP Annual 2024 on our newsroom, and follow us on LinkedIn or X (formerly Twitter).
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.